874j - SYN-004 (Ribaxamase), an Oral β-Lactamase, Prevented Clostridium Difficile Infection and Protected Patients from Colonization by Antimicrobial Resistant Pathogens by Preserving Gut Microbiome Diversity in a Phase 2B Clinical Trial
- Resource Type
- Abstract
- Source
- In
Gastroenterology April 2017 152(5) Supplement 1:S1309-S1309 - Subject
- Language
- ISSN
- 0016-5085